只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-31 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 24,944 | US$9.93 | US$247,693.92 | 17,329,570 | SEC |
| 2026-07-30 2026-07-31 | CAKE CHEESECAKE FACTORY INC | Clark Matthew Eliot Officer · EXEC VP, CFO | 卖出（S） | 68,900 | US$99.30 | US$684.18万 | 45,109 | SEC |
| 2026-07-30 2026-07-31 | EQBK EQUITY BANCSHARES INC | Elliott Brad S Director,Officer · Chief Executive Officer | 卖出（S） | 416 | US$51.02 | US$21,224.32 | 55,313 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 20,824 | US$9.99 | US$208,031.76 | 17,304,626 | SEC |
| 2026-07-29 2026-07-31 | EQBK EQUITY BANCSHARES INC | Elliott Brad S Director,Officer · Chief Executive Officer | 卖出（S） | 4,165 | US$51.12 | US$212,914.80 | 55,313 | SEC |
| 2026-07-28 2026-07-29 | EQBK EQUITY BANCSHARES INC | Elliott Brad S Director,Officer · Chief Executive Officer | 卖出（S） | 6,913 | US$51.01 | US$352,632.13 | 60,672 | SEC |
| 2026-07-28 2026-07-29 | EQBK EQUITY BANCSHARES INC | Elliott Brad S Director,Officer · Chief Executive Officer | 卖出（S） | 5,359 | US$51.06 | US$273,630.54 | 55,313 | SEC |
| 2026-07-28 2026-07-29 | IOT Samsara Inc. | Eltoukhy Adam Officer · SEE REMARKS | 卖出（S） | 3,653 | US$37.00 | US$135,161.00 | 425,080 | SEC |
| 2026-07-27 2026-07-29 | IOT Samsara Inc. | Eltoukhy Adam Officer · SEE REMARKS | 卖出（S） | 2,214 | US$34.44 | US$76,248.39 | 426,519 | SEC |
| 2026-07-27 2026-07-29 | IOT Samsara Inc. | Eltoukhy Adam Officer · SEE REMARKS | 卖出（S） | 1,439 | US$35.73 | US$51,415.76 | 425,080 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-24 2026-07-28 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 41,319 | US$9.99 | US$412,776.81 | 17,283,802 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-23 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 59,880 | US$9.96 | US$596,404.80 | 17,242,483 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 84,124 | US$9.93 | US$835,351.32 | 17,182,603 | SEC |
| 2026-07-22 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 53,378 | US$33.74 | US$180.07万 | 1,558,769 | SEC |
| 2026-07-22 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 7,924 | US$34.79 | US$275,649.02 | 1,550,845 | SEC |
| 2026-07-22 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 50 | US$35.54 | US$1,777.00 | 1,550,795 | SEC |
| 2026-07-22 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 53,436 | US$33.74 | US$180.28万 | 1,359,518 | SEC |
| 2026-07-22 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 7,847 | US$34.81 | US$273,114.84 | 1,351,671 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 120,582 | US$9.55 | US$115.16万 | 17,098,479 | SEC |
| 2026-07-21 2026-07-23 | ADPT Adaptive Biotechnologies Corp | ROBINS HARLAN S Officer · Chief Scientific Officer | 卖出（S） | 278,698 | US$21.72 | US$605.33万 | 1,025,760 | SEC |
| 2026-07-21 2026-07-23 | ADPT Adaptive Biotechnologies Corp | ROBINS HARLAN S Officer · Chief Scientific Officer | 卖出（S） | 213,702 | US$22.12 | US$472.71万 | 812,058 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 111,153 | US$36.43 | US$404.9万 | 1,647,642 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 30,379 | US$37.63 | US$114.31万 | 1,617,263 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 5,116 | US$38.25 | US$195,708.49 | 1,612,147 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 10,600 | US$37.79 | US$400,567.64 | 83,400 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 33,353 | US$36.48 | US$121.68万 | 373,647 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 10,242 | US$37.65 | US$385,582.62 | 363,405 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 1,705 | US$38.24 | US$65,203.63 | 361,700 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 111,489 | US$36.43 | US$406.14万 | 1,448,182 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 29,597 | US$37.62 | US$111.35万 | 1,418,585 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 5,631 | US$38.24 | US$215,319.30 | 1,412,954 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 9,700 | US$37.74 | US$366,047.93 | 84,300 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 900 | US$38.36 | US$34,520.04 | 83,400 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 33,237 | US$36.48 | US$121.25万 | 373,763 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 10,440 | US$37.65 | US$393,060.78 | 363,323 | SEC |
| 2026-07-21 2026-07-23 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,623 | US$38.25 | US$62,079.10 | 361,700 | SEC |
| 2026-07-20 2026-07-21 | IOT Samsara Inc. | Kirchhoff Benjamin Louis Officer · CHIEF ACCOUNTING OFFICER | 卖出（S） | 960 | US$37.70 | US$36,192.00 | 162,800 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-17 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 7,882 | US$8.95 | US$70,543.90 | 16,977,927 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 152,472 | US$8.93 | US$136.16万 | 16,970,045 | SEC |
| 2026-07-16 2026-07-20 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN Officer · Chief Commercial Officer, MRD | 卖出（S） | 5,000 | US$23.00 | US$115,000.00 | 401,288 | SEC |
| 2026-07-15 2026-07-17 | ARQT Arcutis Biotherapeutics, Inc. | Welgus Howard G. Director | 卖出（S） | 4,730 | US$26.91 | US$127,284.30 | 37,109 | SEC |
| 2026-07-15 2026-07-17 | ADPT Adaptive Biotechnologies Corp | LO FRANCIS Officer · Chief People Officer | 卖出（S） | 105,762 | US$22.59 | US$238.92万 | 230,713 | SEC |
| 2026-07-15 2026-07-16 | IOT Samsara Inc. | Kirchhoff Benjamin Louis Officer · CHIEF ACCOUNTING OFFICER | 卖出（S） | 2,549 | US$37.82 | US$96,403.18 | 163,760 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-13 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 6,552 | US$8.94 | US$58,574.88 | 16,817,573 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-10 2026-07-14 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 15,102 | US$8.97 | US$135,464.94 | 16,811,021 | SEC |
| 2026-07-08 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 2,400 | US$35.62 | US$85,499.52 | 1,758,795 | SEC |
| 2026-07-08 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 15,575 | US$35.03 | US$545,559.54 | 1,761,195 | SEC |
| 2026-07-08 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,600 | US$35.64 | US$57,021.44 | 1,559,671 | SEC |
| 2026-07-08 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 17,495 | US$35.04 | US$613,065.04 | 1,561,271 | SEC |
| 2026-07-07 2026-07-09 | SMTC SEMTECH CORP | Green Jason Elliot Officer · EVP and CCO | 卖出（S） | 1,132 | US$129.32 | US$146,387.98 | 9,743 | SEC |
| 2026-07-07 2026-07-09 | SMTC SEMTECH CORP | Green Jason Elliot Officer · EVP and CCO | 卖出（S） | 1,132 | US$130.48 | US$147,697.70 | 8,611 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 154,842 | US$36.57 | US$566.18万 | 1,811,953 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 30,676 | US$37.30 | US$114.43万 | 1,781,277 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 4,507 | US$38.28 | US$172,544.19 | 1,776,770 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 6,600 | US$36.57 | US$241,358.70 | 98,000 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 2,900 | US$37.71 | US$109,354.36 | 95,100 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 1,100 | US$38.35 | US$42,182.03 | 94,000 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 33,489 | US$36.71 | US$122.93万 | 418,811 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 10,586 | US$37.32 | US$395,072.70 | 408,225 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Bicket John Director,Officer,TenPercentOwner · SEE REMARKS | 卖出（S） | 1,225 | US$38.32 | US$46,941.76 | 407,000 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 152,358 | US$36.56 | US$557.06万 | 1,615,313 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 32,728 | US$37.31 | US$122.1万 | 1,582,585 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 3,819 | US$38.29 | US$146,227.22 | 1,578,766 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 6,770 | US$36.58 | US$247,624.94 | 97,830 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 2,930 | US$37.76 | US$110,644.42 | 94,900 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 900 | US$38.35 | US$34,514.01 | 94,000 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 33,841 | US$36.71 | US$124.23万 | 418,459 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 10,059 | US$37.31 | US$375,321.41 | 408,400 | SEC |
| 2026-07-07 2026-07-09 | IOT Samsara Inc. | Biswas Sanjit Director,Officer,TenPercentOwner · CHIEF EXECUTIVE OFFICER | 卖出（S） | 1,400 | US$38.30 | US$53,613.98 | 407,000 | SEC |
| 2026-07-07 2026-07-09 | RIOT Riot Platforms, Inc. | Werner Ryan D. Officer · SVP, CAO | 卖出（S） | 10,232 | US$21.22 | US$217,123.04 | 903,322 | SEC |
| 2026-07-07 2026-07-09 | RIOT Riot Platforms, Inc. | Werner Ryan D. Officer · SVP, CAO | 卖出（S） | 7,596 | US$21.93 | US$166,580.28 | 895,726 | SEC |
| 2026-07-06 2026-07-08 | PBYI PUMA BIOTECHNOLOGY, INC. | NOUGUES MAXIMO F Officer · Chief Financial Officer | 卖出（S） | 9,386 | US$8.26 | US$77,556.52 | 230,637 | SEC |
| 2026-07-06 2026-07-08 | PBYI PUMA BIOTECHNOLOGY, INC. | HUNT DOUGLAS M Officer · See Remarks | 卖出（S） | 8,460 | US$8.26 | US$69,904.98 | 196,841 | SEC |
| 2026-07-06 2026-07-08 | PBYI PUMA BIOTECHNOLOGY, INC. | AUERBACH ALAN H Director,Officer,TenPercentOwner · President and CEO | 卖出（S） | 44,058 | US$8.26 | US$364,051.25 | 7,261,671 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 313 | US$83.10 | US$26,010.30 | 107,225 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 833 | US$84.41 | US$70,313.53 | 106,392 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 519 | US$85.84 | US$44,550.96 | 105,873 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 601 | US$86.38 | US$51,914.38 | 105,272 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 387 | US$83.10 | US$32,159.70 | 107,698 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 1,036 | US$84.41 | US$87,448.76 | 106,662 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 645 | US$85.84 | US$55,366.80 | 106,017 | SEC |
| 2026-07-06 2026-07-08 | PTCT PTC THERAPEUTICS, INC. | Boulding Mark Elliott Officer · EXEC. VP AND CLO | 卖出（S） | 745 | US$86.38 | US$64,353.10 | 105,272 | SEC |
| 2026-07-06 2026-07-07 | IOT Samsara Inc. | Eltoukhy Adam Officer · SEE REMARKS | 卖出（S） | 3,653 | US$37.00 | US$135,161.00 | 425,080 | SEC |
| 2026-07-02 2026-07-07 | ADPT Adaptive Biotechnologies Corp | ROBINS HARLAN S Officer · Chief Scientific Officer | 卖出（S） | 239,351 | US$21.74 | US$520.35万 | 1,166,547 | SEC |
| 2026-07-02 2026-07-07 | ADPT Adaptive Biotechnologies Corp | ROBINS HARLAN S Officer · Chief Scientific Officer | 卖出（S） | 146,889 | US$22.45 | US$329.77万 | 1,019,658 | SEC |
| 2026-07-02 2026-07-06 | ADPT Adaptive Biotechnologies Corp | LO FRANCIS Officer · Chief People Officer | 卖出（S） | 44,838 | US$22.59 | US$101.29万 | 230,713 | SEC |
| 2026-07-01 2026-07-06 | ADPT Adaptive Biotechnologies Corp | LO FRANCIS Officer · Chief People Officer | 卖出（S） | 8,743 | US$22.18 | US$193,919.74 | 279,949 | SEC |
| 2026-07-01 2026-07-06 | ADPT Adaptive Biotechnologies Corp | LO FRANCIS Officer · Chief People Officer | 卖出（S） | 42,261 | US$22.50 | US$950,872.50 | 237,688 | SEC |
| 2026-07-01 2026-07-06 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN Officer · Chief Commercial Officer, MRD | 卖出（S） | 487 | US$22.00 | US$10,714.00 | 406,288 | SEC |
| 2026-07-01 2026-07-02 | IOT Samsara Inc. | Phillips Dominic Officer · SEE REMARKS | 卖出（S） | 12,065 | US$33.32 | US$402,033.55 | 836,100 | SEC |
| 2026-07-01 2026-07-02 | IOT Samsara Inc. | Phillips Dominic Officer · SEE REMARKS | 卖出（S） | 17,909 | US$33.32 | US$596,795.93 | 1,078,600 | SEC |
| 2026-07-01 2026-07-01 | AXSM Axsome Therapeutics, Inc. | TABUTEAU HERRIOT Director,Officer,TenPercentOwner · Chief Executive Officer | 卖出（S） | 49,666 | US$240.25 | US$1193.23万 | 7,229 | SEC |
| 2026-06-30 2026-07-02 | LEGN Legend Biotech Corp | Casey Patrick John Director | 卖出（S） | 6,000 | US$14.80 | US$88,800.00 | 48,604 | SEC |
| 2026-06-29 2026-06-30 | ADPT Adaptive Biotechnologies Corp | BENZENO SHARON Officer · Chief Commercial Ofc Imm Med | 卖出（S） | 154,768 | US$21.14 | US$327.18万 | 221,278 | SEC |
| 2026-06-29 2026-06-30 | IOT Samsara Inc. | Eltoukhy Adam Officer · SEE REMARKS | 卖出（S） | 2,039 | US$32.08 | US$65,411.12 | 425,080 | SEC |
| 2026-06-26 2026-07-02 | BNR Burning Rock Biotech Ltd | Han Yusheng Director | 买入（P） | 24,900 | US$8.00 | US$199,090.44 | 18,404,086 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 180 | US$633.93 | US$114,107.40 | 21,017.3 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 120 | US$634.83 | US$76,179.60 | 20,897.3 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 324 | US$632.81 | US$205,030.44 | 21,197.3 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 360 | US$631.29 | US$227,264.40 | 21,521.3 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 17 | US$629.78 | US$10,706.26 | 21,881.3 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 449 | US$627.44 | US$281,720.56 | 22,581.3 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 173 | US$625.29 | US$108,175.17 | 23,030.3 | SEC |
| 2026-06-26 2026-06-30 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 683 | US$628.94 | US$429,566.02 | 21,898.3 | SEC |
| 2026-06-26 2026-06-30 | ADPT Adaptive Biotechnologies Corp | BENZENO SHARON Officer · Chief Commercial Ofc Imm Med | 卖出（S） | 11,034 | US$21.00 | US$231,714.00 | 272,751 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 1,876 | US$8.98 | US$16,846.48 | 16,795,919 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 837,914 | US$106.50 | US$8923.78万 | 1,960,881 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 51,858 | US$106.50 | US$552.29万 | 78,787 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 113,289 | US$106.50 | US$1206.53万 | 240,123 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND II LP Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-26 2026-06-26 | KYMR Kymera Therapeutics, Inc. | Biotechnology Value Trading Fund OS LP Director,Other | 卖出（S） | 627,597 | US$106.50 | US$6683.91万 | 1,592,261 | SEC |
| 2026-06-25 2026-06-29 | ADPT Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE Director | 卖出（S） | 52,084 | US$20.18 | US$105.11万 | 15,625 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund III, L.P. Director | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Nexus Fund, L.P. Director | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ARTV Artiva Biotherapeutics, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 31,000 | US$8.88 | US$275,280.00 | 16,794,043 | SEC |
| 2026-06-25 2026-06-29 | ADPT Adaptive Biotechnologies Corp | BOBULSKY SUSAN Officer · Chief Commercial Officer, MRD | 卖出（S） | 5,000 | US$20.50 | US$102,500.00 | 406,775 | SEC |
| 2026-06-25 2026-06-29 | LEGN Legend Biotech Corp | Huang Ying Director,Officer · Chief Executive Officer | 卖出（S） | 5,566 | US$14.78 | US$82,265.48 | 241,872 | SEC |
| 2026-06-25 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 240 | US$629.95 | US$151,188.00 | 20,897.3 | SEC |
| 2026-06-25 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 240 | US$628.25 | US$150,780.00 | 21,137.3 | SEC |
| 2026-06-25 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 24 | US$627.80 | US$15,067.20 | 21,377.3 | SEC |
| 2026-06-25 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 132 | US$626.00 | US$82,632.00 | 21,401.3 | SEC |
| 2026-06-25 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 547 | US$625.39 | US$342,088.33 | 21,533.3 | SEC |
| 2026-06-25 2026-06-26 | KRYS Krystal Biotech, Inc. | Thomas John Charles Officer · EVP, General Counsel | 卖出（S） | 1,000 | US$347.27 | US$347,270.00 | 0 | SEC |
| 2026-06-24 2026-07-02 | BNR Burning Rock Biotech Ltd | Han Yusheng Director | 买入（P） | 250,000 | US$8.00 | US$200万 | 18,379,186 | SEC |
| 2026-06-24 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 175 | US$603.45 | US$105,603.75 | 20,897.3 | SEC |
| 2026-06-24 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 355 | US$602.43 | US$213,862.65 | 21,072.3 | SEC |
| 2026-06-24 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 1,261 | US$601.25 | US$758,176.25 | 21,427.3 | SEC |
| 2026-06-24 2026-06-26 | CACC CREDIT ACCEPTANCE CORP | Elliott Nicholas J Officer · Chief Transformation Officer | 卖出（S） | 1,696 | US$600.29 | US$101.81万 | 22,688.3 | SEC |
| 2026-06-23 2026-07-02 | BNR Burning Rock Biotech Ltd | Han Yusheng Director | 买入（P） | 5,990 | US$7.50 | US$44,920.21 | 18,129,186 | SEC |
| 2026-06-23 2026-06-24 | AMPG AmpliTech Group, Inc. | Mazziota Daniel Richard Director | 卖出（S） | 10,000 | US$7.71 | US$77,100.00 | 237,743 | SEC |
| 2026-06-22 2026-07-02 | BNR Burning Rock Biotech Ltd | Han Yusheng Director | 买入（P） | 104,650 | US$7.45 | US$779,673.90 | 18,123,196 | SEC |
| 2026-06-22 2026-06-24 | AMPG AmpliTech Group, Inc. | Mazziota Daniel Richard Director | 卖出（S） | 7,157 | US$8.46 | US$60,548.22 | 247,743 | SEC |
| 2026-06-22 2026-06-24 | RIOT Riot Platforms, Inc. | Les Jason Director,Officer · CEO | 卖出（S） | 62,703 | US$30.09 | US$188.67万 | 1,263,556 | SEC |
| 2026-06-22 2026-06-24 | RIOT Riot Platforms, Inc. | Werner Ryan D. Officer · SVP, CAO | 卖出（S） | 25,375 | US$30.00 | US$761,250.00 | 927,423 | SEC |
| 2026-06-22 2026-06-23 | IOT Samsara Inc. | Eltoukhy Adam Officer · SEE REMARKS | 卖出（S） | 1,614 | US$32.21 | US$51,986.94 | 425,080 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| AIOT | 99,229.8448 | 100 | 177,087.5624 | 56.03% | Q, N |
| IOT | 718,432.6941 | 1,500 | 1,637,187.8499 | 43.88% | B, Q, N |
| BIOT | 147,341 | 35,202 | 512,850.8407 | 28.73% | B, Q, N |
| IOTR | 509 | 0 | 1,773.5544 | 28.70% | Q |
| RIOT | 3,242,243.6145 | 20,547 | 11,322,458.7104 | 28.64% | B, Q, N |
| VIOT | 3,741 | 0 | 14,817 | 25.25% | B, Q, N |
| BIOTW | 2,730 | 430 | 105,497 | 2.59% | Q |